This is not the most recent version of the article. View current version (8 SEP 2010)

Intervention Protocol

Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy

  1. Douglas M Woudstra1,*,
  2. Sue Chandra1,
  3. G Justus Hofmeyr2

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD008148


How to Cite

Woudstra DM, Chandra S, Hofmeyr GJ. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008148. DOI: 10.1002/14651858.CD008148.

Author Information

  1. 1

    University of Alberta, Department of Obstetrics and Gynaecology, Edmonton, Alberta, Canada

  2. 2

    University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health, Department of Obstetrics and Gynaecology, East London Hospital Complex, East London, Eastern Cape, South Africa

*Douglas M Woudstra, Department of Obstetrics and Gynaecology, University of Alberta, 13619 - 108 Avenue, Edmonton, Alberta, T5M 2C7, Canada. dwoudstra@ualberta.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article. View current version (08 SEP 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine, from the best available evidence, the effects of corticosteroids on maternal and perinatal mortality and morbidity in women with HELLP syndrome.